Molecular Weight: Approximately 1096.34 (or 1096.323, 1096.33, slight differences may exist depending on the source).
Physical Properties
Appearance: White to off-white solid, typically presented as a white lyophilized cake or white powder.
Density: Approximately 1.4±0.1 g/cm3.
Boiling Point: Approximately 1508.2±65.0 °C at 760 mmHg.
Flash Point: Approximately 865.9±34.3 °C.
Solubility: Specific solubility data in water is not provided, but peptide drugs generally have limited solubility in water.
Chemical Properties
Stability: Should be stored under low temperature, light-protected, sealed, and dry conditions to ensure its stability.
Reactivity: As a peptide drug, Lanreotide Acetate may react with other chemicals, so it should be avoided from contacting incompatible substances during use and storage.
Pharmacological Effects
Somatostatin Analog: Lanreotide Acetate is a synthetic analog of somatostatin with similar activity but a longer duration of action and higher affinity for peripheral receptors.
Hormone Secretion Inhibition: Lanreotide Acetate inhibits the release of hormones such as growth hormone, thyroid-stimulating hormone (TSH), insulin, and glucagon, with a particularly significant inhibitory effect on growth hormone secretion.
Antitumor Activity: Lanreotide Acetate also has antitumor activity and can be used to treat neuroendocrine tumors, gastrointestinal neuroendocrine tumors, and carcinoid syndrome.
